Ads
related to: abbott diabetes care
Search results
Abbott Diabetes Care CMO Mahmood Kazemi on expanding CGM access
MedTech Dive via Yahoo Finance· 6 months agoThe Centers for Medicare and Medicaid Services in April expanded Medicare coverage of continuous...
Abbott's (ABT) Q2 Earnings Top Estimates, 2022 EPS View Up
Zacks via Yahoo Finance· 2 years agoAbbott's (ABT) Diabetes Care business continues to benefit from the growing sales of its flagship,...
Abbott (ABT) Diabetes Arm Growth Robust Amid Macroeconomic Woes
Zacks via Yahoo Finance· 1 year agoAbbott (ABT) currently forecasts total organic sales growth, excluding the impact of COVID...
Could Abbott Laboratories Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 5 months agoAbbott Laboratories (NYSE: ABT) is a longtime leader in the healthcare industry. The medical device...
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 month agoImage source: The Motley Fool. Abbott Laboratories (NYSE: ABT) Q1 2024 Earnings Call Apr 17, 2024,...
Abbott (ABT) Medical Devices Arm Gains Traction, FX Woe Stays
Zacks via Yahoo Finance· 2 years agoAbbott Laboratories ABT is well poised for growth in the coming quarters, backed by its progress in...
Abbott (ABT) FreeStyle Libre 2 Gets Reimbursement in France
Zacks via Yahoo Finance· 11 months agoAbbott Laboratories ABT recently announced that the FreeStyle Libre 2 system's reimbursement...
Abbott (ABT) FreeStyle Libre 3 System's Study Outcome Favorable
Zacks via Yahoo Finance· 2 years agoAbbott Laboratories ABT presented late-breaking clinical data that demonstrate the FreeStyle Libre 3...
Abbott (ABT) Closes Acquisition Deal of Bigfoot Biomedical
Zacks via Yahoo Finance· 8 months agoAbbott Laboratories, Inc. ABT recently completed its previously announced acquisition of Bigfoot...
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
Motley Fool via Yahoo Finance· 3 months agoAnti-obesity drugs rose in popularity last year, helping the leaders in this market -- notably Eli...
